Skip directly to page options Skip directly to A-Z link

Volume 21, Number 5—May 2015

Research

Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin

Nicaise Tuikue NdamComments to Author , Lise Denoeud-Ndam, Justin Doritchamou, Firmine Viwami, Ali Salanti, Morten A. Nielsen, Nadine Fievet, Achille Massougbodji, Adrian J.F. Luty, and Philippe Deloron
Author affiliations: Institut de Recherche pour le Développement, Paris, France (N. Tuikue Ndam, L. Denoeud-Ndam, J. Doritchamou, N. Fievet, A.J.F. Luty, P. Deloron); Pôle de Recherche et d’Enseignement Supérieur Sorbonne Paris Cité, Paris (N.Tuikue Ndam, N. Fievet, A.J.F. Luty, P. Deloron),; Université d’Abomey-Calavi, Cotonou, Benin (F. Viwami, A. Massougbodji, A.J.F. Luty); University of Copenhagen, Copenhagen, Denmark (A. Salanti, M.A. Nielsen)

Main Article

Table 2

Percentage of antibody responders, by parity, in study of protective antibodies against placental malaria and poor outcomes during pregnancy, Benin*

Antigen or assay Enrollment
 Delivery
All, n = 710 Primigravidae, n = 115 Multigravidae, n = 595 p value All, n = 710 Primigravidae, n = 115 Multigravidae, n = 595 p value
AMA1 77 73 78 0.265 69 70 69 0.732
VSA 67 46 71 <0.0001 58 32 63 <0.0001
DBL1–DBL2 53 41 56 0.005 46 25 50 <0.0001
DBL3 65 45 69 <0.0001 51 28 55 <0.0001
DBL4 42 40 43 0.569 46 26 50 0.002
DBL5 71 55 74 <0.0001 58 49 60 0.035
DBL6 67 70 66 0.607 81 85 80 0.434
FV2 71 51 75 <0.0001 81 70 83 0.004
IBA 59 42 62 <0.0001 66 61 67 0.168

*Antibody responders were defined as persons having an antibody level beyond the threshold. The threshold was defined for each antigen as mean reactivity + 3 SD for 30 unexposed French pregnant women. AMA1, apical membrane antigen 1; VSA, variant surface antigen; DBL, Duffy binding-like antigen; FV2, full-length ectodomain of variant surface antigen 2 chondroitin sulfate; IBA, inhibition of binding assay.

Main Article

Page created: April 17, 2015
Page updated: April 17, 2015
Page reviewed: April 17, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external